AzTrials
AzTrials

DeliriumSCREEN-EDNCT02801851

Delirium Screening of the Elderly in the Emergency Department

A study testing SCREEN-ED in people with Delirium, run by Northeastern University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will refine and pilot test an innovative, emergency department (ED)-based intervention for delirium screening, initial management, and communication with inpatient providers, and examine the impact of this intervention on the rate of documentation of delirium in the electronic health record by ED and… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Delirium
What is being tested?
SCREEN-ED
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
Jul 2015to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • 65 years presenting to the ED between 2pm and 11pm (highest ED census) 7 days a week

Who cannot join

  • Patients who are being evaluated for severe head injury and those who present with delirium tremens due to the difficulty of distinguishing delirium from head injury and because delirium tremens has a distinct etiology, course and outcomes.
  • Patients who are aphasic, comatose, terminally ill, deaf, or are non-English speaking.

Trial locations and contacts

1 site in 1 country.

Jane Saczynski, PhD contact

617-373-5212

j.saczynski@neu.edu

United States1 site, 1 recruiting
  • UMass Medical School

    Worcester, Massachusetts, 01655

    Chad Darling, MD

    Jane Saczynski, PhD

    Recruiting

Other trials in United States

About this study

This study will refine and pilot test an innovative, emergency department (ED)-based intervention for delirium screening, initial management, and communication with inpatient providers, and examine the impact of this intervention on the rate of documentation of delirium in the electronic health record by ED and inpatient providers. To achieve this, the study will develop and pilot test an intervention, Delirium Screening (SCREEN-ED) in the ED, involving 300 older patients (150 newly enrolled intervention participants, 150 historical controls (comparison group) currently being collected), that has 4 key components: systematic screening for delirium using the Confusion Assessment Method (CAM), informing providers of the screening result, a checklist protocol for initial delirium management based on clinical guidelines, and documentation in the Electronic Health Record (EHR) and communication with inpatient providers of delirium screening results.

The study has two primary aims. The first is to refine and test the feasibility and acceptability of the SCREEN-ED intervention. The second is to examine the impact of SCREEN-ED on rate of delirium documentation and secondary outcomes (length of hospital stay, repeat ED visits and hospitalizations and mortality over 6-months) in the 150 newly enrolled intervention group compared with 150 already collected historical controls.

Read the detailed description

The investigators will develop and pilot test an intervention, Delirium Screening (SCREEN-ED) in the ED, involving 300 older patients (150 newly enrolled intervention participants, 150 historical controls (comparison group) currently being collected), that has 4 key components: systematic screening for delirium using the CAM, informing providers of the screening result, a checklist protocol for initial delirium management based on clinical guidelines, and documentation in the Electronic Health Record (EHR) and communication with inpatient providers of delirium screening results. The short-term goal is to test the feasibility and acceptability of the intervention, and its immediate impact on documentation of delirium in the EHR. The long-term goal is to utilize the information gleaned from this developmental study to inform a large-scale multi-center randomized clinical trial to test the impact of the SCREEN-ED strategy on clinical outcomes including length of stay, repeat ED visits, rehospitalization, and mortality.

The study will enroll 150 patients to the intervention arm and will screen them for delirium using the CAM. The screening results (positive or negative) will be provided verbally and in the EHR to ED providers, and, in screen positive cases, ED physicians will be provided with a checklist protocol for delirium management that will be embedded in the ED EHR. Additionally, in admitted patients, the screening result will be entered into the inpatient EHR. The study team will review ED and inpatient medical records and compare physician documentation of delirium in SCREEN-ED compared with a historical comparison group currently being collected.

The study will follow all patients (intervention and comparison) through medical record review for 6 months to collect clinical outcomes, which will be examined as secondary outcomes. The study will also examine the acceptability of the intervention with ED and inpatient providers through focus groups prior to the roll-out of SCREEN-ED to refine the intervention components and again in year 2 of the study, after the intervention period is complete, to identify barriers and facilitators to intervention implementation.

Using the same system used to enroll the historical comparison group, patients will be identified using the real-time ED EHR (PulseCheck™), which is populated on arrival with detailed clinical information and links with the hospital EHR. After initial eligibility screen, patients will be approached by trained study staff and introduced to the study. Informed consent will be obtained and study staff will use a standardized Capacity for Informed Consent Instrument that combines capacity assessment questions with interviewer observation and that is used in a prior ED delirium study. If the patient fails the Capacity assessment, a proxy will be asked to provide consent (with patient assent).

The PIs have worked to seamlessly integrate their staff into the workflow of the ED. They expect enrollment to last ~40 weeks, requiring 4 patients be enrolled per week to meet a sample size of 150 in the intervention group (recruitment rate of <10%, assuming 200 patients per week of which 25% are ineligible and 50% refuse).

The pilot SCREEN-ED intervention will test whether screening for delirium in the ED combined with a checklist protocol for initial management is feasible and acceptable and increases EHR documentation of delirium. Consenting participants enrolled in SCREEN-ED will be administered a brief (<10 minutes), standardized questionnaire by a trained study staff member from which the CAM will be scored. Immediately following the interview, the study staff member will score the CAM and the screening result (positive or negative) and, in positive cases, the severity stage of delirium (mild, moderate, severe) will be entered into the EHR and verbally communicated to providers. For patients who screen positive, the checklist protocol for delirium management will automatically appear in the EHR and the ED physicians will be prompted to review and complete all applicable checklist items. In cases where the patient is admitted, the diagnosis and severity will be entered into the EHR and the admitting physicians will be directly informed through existing structured verbal and written communication between the ED and admitting providers.

After the intervention period, the study team will conduct additional focus groups with 10 providers (MDs and nurses), including representatives from inpatient services , who will provide qualitative data on the feasibility of implementation of the intervention and contribute to systematic evaluation using the REAIM (reach, effectiveness, adoption, implementation, maintenance) framework. The investigators will use a widely used focus-group methodology designed to elicit a range of ideas, attitudes, experiences and reactions from providers on the SCREEN-ED strategy. Semi-structured interview scripts will be developed to generate discussion about providers' experiences with SCREEN-ED and changes in the management of older patients as a result of its use. The checklist items will provide the overall structure to the focus group discussions. Information from the focus groups, providing direct accounts of provider experience, will compliment adherence data collected from medical record review. Inpatient providers will describe how checklist protocols (e.g., diagnosis, treatment \& communication) impacted the care they provided (e.g., Did they do anything differently knowing the patient was diagnosed with delirium? Did results from initial work-up contribute to their approach to the patient?). It is anticipated that with three focus groups saturation will be reached (i.e., no new ideas are being contributed). However, if this is not the case additional providers will be enrolled and conduct additional groups until saturation is achieved.

Participants enrolled in an ongoing study of delirium that is validating a tool for family members to identify delirium against the CAM will serve as the historical comparison group. This study, which began enrollment in September 2013, has enrolled 120 participants to date by enrolling approximately 2 days a week. The study will enroll intervention patients as soon as possible after completion of comparison group enrollment to minimize temporal separation and enhance comparability. Participants in the comparison group are screened for delirium using the CAM following the same procedures described above for the intervention group. Because the CAM is being used as the gold-standard against which to compare the new screening instrument and was not being administered for screening purposes, CAM results are not communicated to providers, are not incorporated into the EHR, and providers are not given a delirium management checklist. Medical record abstraction elements in the intervention and comparison groups will be identical.

Conditions
Delirium
Being tested
SCREEN-ED
Keywords
Delirium
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SCREEN-EDBehavioural

    SCREEN-ED will have 4 key components: systematic screening for delirium using the CAM; informing providers of the screening result; a checklist protocol for initial delirium management based on clinical guidelines tailored to the ED, which includes identification of cause, risk factor modification, and behavioral interventions; documentation in the Electronic Health Record (EHR) and communication with inpatient providers of delirium screening results.

Study groups in NCT02801851
Study groupRoleWhat they receive
Intervention SCREEN-EDExperimentalThis is the arm that will receive the SCREEN-ED. SCREEN-ED is an innovative, yet practical intervention that combines screening with informing clinicians of the results and provides a checklist for delirium management that is tailored to the time-limited ED setting.
Receives: Behavioral: SCREEN-ED

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Count of Delirium Diagnoses in EHR

    Count of delirium diagnoses in the EHR of study subjects

    Measured: 6 months

Secondary outcomes (5)
  1. Count of Hospitalizations in participants

    Count of Hospitalizations in study subjects 6 months post-enrollment

    Measured: 6 months

  2. Focus group content analysis for SCREEN-ED intervention feasibility

    Feasibility and acceptability of SCREEN-ED will be assessed from qualitative interviewers with providers as evaluated by REAIM (reach, effectiveness, adoption, implementation, maintenance) Framework which measures the acceptability, impact, and importance of an evaluation. This will be augmented by post-intervention focus group with 10 providers.

    Measured: months 4-16

  3. Count of ED visits in participants

    ED visits in the 6 months post-enrollment

    Measured: 6 months

  4. Length of hospital stay in days in participants

    Length of hospital stays in days if hospitalized again in the 6 months post-enrollment

    Measured: 6 months

  5. Mortality

    Mortality of participants in the 6 months post-enrollment

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2016 (estimated)
  2. Study startJul 2015
  3. Primary completionMar 2017 (estimated)
  4. Study completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02801851
Sponsor's protocol ID
UMASS Saczynski
Acronym
SCREEN-ED
Status last verified
Jun 2016
First submitted
29 Mar 2016
Last updated
19 Jul 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28.

    PubMed 23992774
  • Elie M, Rousseau F, Cole M, Primeau F, McCusker J, Bellavance F. Prevalence and detection of delirium in elderly emergency department patients. CMAJ. 2000 Oct 17;163(8):977-81.

    PubMed 11068569
  • Hustey FM, Meldon SW. The prevalence and documentation of impaired mental status in elderly emergency department patients. Ann Emerg Med. 2002 Mar;39(3):248-53. doi: 10.1067/mem.2002.122057.

    PubMed 11867976
  • Kakuma R, du Fort GG, Arsenault L, Perrault A, Platt RW, Monette J, Moride Y, Wolfson C. Delirium in older emergency department patients discharged home: effect on survival. J Am Geriatr Soc. 2003 Apr;51(4):443-50. doi: 10.1046/j.1532-5415.2003.51151.x.

    PubMed 12657062
  • Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999 Mar 4;340(9):669-76. doi: 10.1056/NEJM199903043400901.

    PubMed 10053175
  • Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823-30. doi: 10.1111/j.1532-5415.2008.01674.x. Epub 2008 Apr 1.

    PubMed 18384586

Questions about this trial

What is this clinical trial studying?

A study testing SCREEN-ED in people with Delirium, run by Northeastern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jane Saczynski, PhD (617-373-5212, j.saczynski@neu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Count of Delirium Diagnoses in EHR (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02801851, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in